Table 2 Univariate analysis in relation to 30-day mortality.
Variables | Statistics | OR (95% CI) | P value |
|---|---|---|---|
Age (year) | 77.64 ± 12.32 | 1.10 (1.07, 1.13) | < 0.0001 |
Gender | |||
Male | 341 (43.49%) | Reference | |
Female | 443 (56.51%) | 1.28 (0.79, 2.08) | 0.3242 |
Department | |||
Medical | 781 (99.62%) | Reference | |
Surgical | 3 (0.38%) | 19.11 (1.71, 213.26) | 0.0165 |
Ischemic stroke subtypes (TOAST) | |||
Large-artery atherosclerosis | 71 (9.06%) | Reference | |
Cardioembolism | 70 (8.93%) | 0.49 (0.12, 2.02) | 0.3204 |
Small-vessel occlusion | 30 (3.83%) | 1.67 (0.43, 6.39) | 0.4564 |
Other determined etiology | 2 (0.26%) | 10.83 (0.60, 195.96) | 0.1068 |
Undetermined | 611 (77.93%) | 1.22 (0.51, 2.94) | 0.6520 |
GPR | 1.59 ± 0.40 | 2.18 (1.31, 3.63) | 0.0028 |
Serum-glucose (mmol/L) | 6.46 ± 1.35 | 1.33 (1.14, 1.55) | 0.0003 |
Serum-potassium (mmol/L) | 4.12 ± 0.42 | 1.32 (0.76, 2.29) | 0.3327 |
Serum-sodium (mmol/L) | 139.50 ± 3.60 | 1.07 (0.99, 1.15) | 0.0859 |
Serum-calcium (mmol/L) | 2.35 ± 0.12 | 0.20 (0.03, 1.48) | 0.1159 |
Serum-albumin (g/L) | 39.21 ± 3.87 | 0.82 (0.78, 0.87) | < 0.0001 |
Serum-phosphate tertiles (mmol/L), n (%) | |||
Tertile1 (≤ 0.97) | 85 (10.84%) | Reference | |
Tertile2 (0.98–1.12) | 88 (11.22%) | 1.52 (0.59, 3.93) | 0.3874 |
Tertile3 (≥ 1.13) | 100 (12.76%) | 1.44 (0.57, 3.65) | 0.445 |
Not recorded | 511 (65.18%) | 0.88 (0.40, 1.95) | 0.7611 |
Serum-magnesium tertiles (mmol/L), n (%) | |||
Tertile1 (≤ 0.78) | 87 (11.10%) | Reference | |
Tertile2 (0.79–0.84) | 89 (11.35%) | 0.97 (0.37, 2.59) | 0.9594 |
Tertile3 (≥ 0.85) | 107 (13.65%) | 1.52 (0.64, 3.64) | 0.3431 |
Not recorded | 501 (63.90%) | 0.79 (0.37, 1.69) | 0.5492 |
Hyperlipemia, n (%) | |||
No | 754 (96.17%) | Reference | |
Yes | 30 (3.83%) | – | § |
Hypertension, n (%) | |||
No | 593 (75.64%) | Reference | |
Yes | 191 (24.36%) | 0.50 (0.26, 0.96) | 0.0378 |
AF, n (%) | |||
No | 575 (73.34%) | Reference | |
Yes | 209 (26.66%) | 1.40 (0.84, 2.32) | 0.1973 |
Heart failure, n (%) | |||
No | 761 (97.07%) | Reference | |
Yes | 23 (2.93%) | 5.44 (2.22, 13.28) | 0.0002 |
Chronic renal failure, n (%) | |||
No | 751 (95.79%) | Reference | |
Yes | 33 (4.21%) | 4.51 (2.06, 9.89) | 0.0002 |
Acute renal failure | |||
No | 766 (97.70%) | Reference | |
Yes | 18 (2.30%) | 1.90 (0.54, 6.71) 0.3197 | 0.3197 |
COPD, n (%) | |||
No | 774 (98.72%) | Reference | |
Yes | 10 (1.28%) | 2.36 (0.49, 11.34) | 0.2819 |
CHD, n (%) | |||
No | 742 (94.64%) | Reference | |
Yes | 42 (5.36%) | 1.28 (0.49, 3.35) | 0.6195 |
Cancer, n (%) | |||
No | 770 (98.21%) | Reference | |
Yes | 14 (1.79%) | 1.57 (0.34, 7.14) | 0.5611 |
Malnutrition, n (%) | |||
No | 766 (97.70%) | Reference | |
Yes | 18 (2.30%) | 1.17 (0.26, 5.18) | 0.8373 |
Dehydration, n (%) | |||
No | 755 (96.30%) | Reference | |
Yes | 29 (3.70%) | 1.52 (0.51, 4.48) | 0.8598 |
Pneumonia, n (%) | |||
No | 748 (95.41%) | Reference | |
Yes | 36 (4.59%) | 9.17 (4.52, 18.63) | < 0.0001 |
